Eli Lilly and Regeneron are among the first seven companies the FDA has selected for its PreCheck Pilot Program, CNBC has learned.
Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities
– Advertisement –
Trump says Iran talks to resume after US called off major attack
AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports
Uefa threatens legal action over Infantino’s failed Fifa commercialisation